PARKWOOD HOSPITAL
1. Target Overview & Investment Thesis
PARKWOOD HOSPITAL is a 108-bed safety-net/medicaid heavy in DESOTO, MS with $26.3M in net patient revenue and a 8.2% operating margin. The hospital serves a payer mix of 16.3% Medicare, 33.0% Medicaid, and 50.7% commercial.
Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.2% to 15.6% (+736bps).
| Net Revenue HCRIS | $26.3M |
| Current EBITDA COMPUTED | $2.2M |
| Operating Margin COMPUTED | 8.2% |
| Occupancy HCRIS | 54.0% |
| Revenue / Bed COMPUTED | $244K |
| Net-to-Gross HCRIS | 37.1% |
| Distress Probability ML | 56.1% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 8.2% places it above the state median. Among 25 size-comparable peers (54-216 beds), the median margin is -4.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (54-216), prioritizing same-state peers. 25 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PARKWOOD HOSPITAL (Target) | MS | 108 | $26.3M | 8.2% |
| BAPTIST MEM HOSPITAL NORTH MIS | MS | 195 | $229.4M | 0.7% |
| BAPTIST MEM HOSPITAL GOLDEN TR | MS | 154 | $221.1M | 6.9% |
| MAGNOLIA HOSPITAL | MS | 158 | $161.6M | -4.7% |
| MERIT HEALTH WESLEY | MS | 121 | $140.9M | 1.3% |
| RIVER OAKS HOSPITAL | MS | 158 | $124.1M | 7.0% |
| SOUTHWEST MS REGIONAL MED CENT | MS | 97 | $123.1M | -16.0% |
| RUSH FOUNDATION HOSPITAL | MS | 191 | $122.0M | -19.1% |
| BAPTIST MEM HOSPITAL UNION COU | MS | 83 | $117.9M | 3.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $553K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $526K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $521K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $320K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $17K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $2.2M |
| + RCM Uplift | +$1.9M |
| Pro Forma EBITDA | $4.1M |
| Current Margin | 8.2% |
| Pro Forma Margin | 15.6% |
| WC Released (1x) | $1.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $3.3M | $33.7M | 10.09x | 58.8% |
| Base (11x exit) | 10.0x | 11.0x | $3.3M | $38.1M | 11.42x | 62.8% |
| Bull Case | 9.0x | 11.0x | $3.0M | $45.6M | 15.18x | 72.3% |
| Bull (12x exit) | 9.0x | 12.0x | $3.0M | $50.7M | 16.85x | 75.9% |
| Bear Case | 11.0x | 10.0x | $3.7M | $22.9M | 6.24x | 44.2% |
| Bear (11x exit) | 11.0x | 11.0x | $3.7M | $26.4M | 7.19x | 48.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (33.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 56.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 25 hospitals with 54-216 beds
- Same-state prioritization (n=26)
- Comp margins: P25=-16.1% / P50=-4.0% / P75=2.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.